NCT02766517 - Biomarker Study in Participants With Migraine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 28, 2016

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2017

Conditions

Migraine Disorders

Interventions

DRUG

Capsaicin

Administered topically

Trial Locations (14)

Rochester Clinical Research, Inc., Rochester

PharmaSite Research Inc, Baltimore

PAREXEL-Phase 1 Baltimore Harbor Hospital Center, Baltimore

Avail Clinical Research LLC, DeLand

Psychiatric Inst of Florida-Clinical Neuroscience Solutions, Orlando

CNS Health Care, Memphis

Arizona Research Center, Phoenix

Pharmacology Research Institute, Newport Beach, Los Alamitos

Pharmacology Research Institute, Newport Beach, Encino

Medical Center for Clinical Research, San Diego

California Clinical Trials, San Diego

Pharmacology Research Institute, Newport Beach, Newport Beach

Parexel Early Phase Unit at Glendale, Glendale

Northwest Clinical Research Center, Bellevue

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY